As an entrepreneur-scientist, Dr. Bostian has held executive operating roles in companies financed by leading venture firms in the biotechnology arena, and has played advisory roles at the seed, pre-seed, and investment stage for numerous other organizations, securing over $275 million in financing from corporate partners and investors. Previous to VBS/Amalyte, he was a founder of Mpex Pharmaceuticals, a development-stage pharmaceutical company with discovery, preclinical and late clinical stage programs in the infectious disease arena, the founder and CEO of Iconix Pharmaceuticals, Inc., a pioneer and leader in the emerging field of chemogenomics, as well as founder and COO of Microcide...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
